Remdesivir for COVID-19 in Hospitalized Children: A Phase 2/3 Study

• DOI: 10.1542/peds.2023-063775
• Publication Date: 2024-02-09T08:18:17Z
• Authors: Amina Ahmed; Flor M. Munoz; William J. Muller; Allison Agwu; David W. Kimberlin; Luisa Galli; Jaime G. Deville; Paul K. Sue; Ana Mendez-Echeva...; Rita Humeniuk; Susan Guo; Lauren Rodriguez; Dong Han; Charlotte Hedskog; Heather Maxwell; Ramesh Palaparthy; Kathryn Kersey; Pablo Rojo
• Keywords: Adult; 0301 basic medicine; Alanine; SARS-CoV-2; Infant; COVID-19; Adenosine Monophosphate; COVID-19 Drug Treatment; 03 medical and health sciences; Humans; Pyrroles; Child; Child, Hospitalized; Transaminases

Remdesivir decreases the risk of SARS-CoV-2 infection progressing to severe disease in adults. This study evaluated remdesivir safety and pharmacokinetics infants children.